Product Information
ZOLPIDEM TARTRATE 7.5 MG CAP is a generic product labeled by Almatica Pharma LLC, priced at $7.9333 per EA under NDC 52427077530. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on May 9, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Almatica Pharma LLCNDC
52427077530
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ZOLPIDEM TARTRATEApproval Type
New Drug (NDA)
FDA Application
NDA215721FDA Approved
5/9/2023
TE Code
AB
On Market Since
5/9/2023
Pharmacological Classes
Price Statistics
The NADAC for ZOLPIDEM TARTRATE 7.5 MG CAP has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.9333 per EA |
|---|---|
| All-time high | $8.0059 (Oct 16, 2024) |
| All-time low | $7.9333 (Aug 19, 2026) |
| 52-week high | $7.9659 |
| 52-week low | $7.9333 |
| Median price | $7.9658 |
| Average price | $7.9705 |
| Largest weekly change | -0.3% (Aug 19, 2026) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the zolpidem tartrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Almatica Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
zolpidem tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
gamma-Aminobutyric Acid A Receptor Positive Modulator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZOLPIDEM TARTRATE 7.5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for ZOLPIDEM TARTRATE 7.5 MG CAP, manufactured by Almatica Pharma LLC, is $7.9333 per EA (NDC 52427077530), effective Sep 30, 2026.
How has the price of ZOLPIDEM TARTRATE 7.5 MG CAP changed over time?
Over the history we have for it, the NADAC for ZOLPIDEM TARTRATE 7.5 MG CAP has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ZOLPIDEM TARTRATE 7.5 MG CAP?
Since Apr 17, 2024, the NADAC for ZOLPIDEM TARTRATE 7.5 MG CAP has ranged from a low of $7.9333 (Aug 19, 2026) to a high of $8.0059 (Oct 16, 2024), with a median of $7.9658 per EA.
Are there cheaper alternatives to ZOLPIDEM TARTRATE 7.5 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of ZOLPIDEM TARTRATE 7.5 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZOLPIDEM TARTRATE 7.5 MG CAP?
ZOLPIDEM TARTRATE 7.5 MG CAP (NDC 52427077530) is labeled by Almatica Pharma LLC, and CMS classifies it as a generic product.